Improved access to psychological therapies in north east London for those affected by personality disorder

2012-12-21 09:57:00

Improved access to psychological therapies in north east London for those affected by personality disorder

Personality disorder services run by North East London NHS Foundation Trust have become a national demonstrator site for outstanding work that has shown positive results for patients.

The Department of Health announced on Wednesday (19 December 2012) that North East London NHS Foundation Trust (NELFT) is one of just three NHS healthcare organisations in England to be a national Improving Access to Psychological Therapies (IAPT) Severe Mental Illness (SMI) demonstrator site for people affected by personality disorder.

The Improving Access to Psychological Therapies (IAPT) programme is a national NHS initiative that aims to increase significantly the availability of psychological therapies for psychosis, bipolar disorder and personality disorder.

Good mental health is fundamental to our physical health, relationships, education/work and achieving our potential, and brings wide social and economic benefits to individuals and society.

Personality disorders are severe and enduring mental health disorders leading to significant impairment and distress for individuals, their families, and their communities.

NELFT runs personality disorder services in the north east London Boroughs of Barking and Dagenham, Havering, Redbridge and Waltham Forest.

Care and Support Minister, Norman Lamb MP said: “These IAPT demonstrator sites will benefit those with the most severe mental illnesses and personality disorders and will help policy makers, commissioners and providers better understand how we can ensure people get the right help and support that is needed.

“The successful sites have been chosen for their experience in delivering successful support and treatment and I look forward to seeing the results of this initiative.”

Now that the NELFT personality disorder services are a national demonstrator site, they will be required to collect information to support the evaluation of service user recovery, satisfaction and health service use. This will help shape psychological therapy services nationally.

Janet Feigenbaum, Chartered Consultant Clinical Psychologist and Strategic and Clinical Lead for Personality Disorder Services at NELFT attended the announcement at the Department of Health on Wednesday.

Janet Feigenbaum said: “The announcement by the Department of Health that the Personality Disorder services at NELFT have been chosen as a national IAPT demonstrator site for personality disorders really does show we are leading the way when it comes to giving people with personality disorders access to psychological therapies as part of their treatment.

“Through the success of the Intensive Management of Personality disorder Assessment and Recovery (IMPART) programmes at NELFT, we have helped more people with personality disorders access services they need at the right time.

IMPART provides a range of evidence-based psychological therapies for individuals with a personality disorder.

Service users receive individual therapy and are taught skills including managing and regulating emotions, interpersonal effectiveness, mindfulness, cognitive restructuring, and distress tolerance.

Janet Feigenbaum added: “Becoming a national demonstrator site is an excellent opportunity for other healthcare providers to learn from the personality disorder services at NELFT, which is providing a good service for people with personality disorders. It can provide a stepping stone to the development of other services across the country.”

“At least one in four people will experience a mental health problem at some stage in their lives. This can place a significant burden on that individual’s wellbeing, their family, the NHS and the wider economy, so it is vital that people with personality disorders have access to the right care, at the right time. This is what we strive to achieve for our patients at North East London NHS Foundation Trust.”

<< Go back